LINC00485

Across TCGA pan-cancer cohorts, LINC00485 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC00485’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where LINC00485 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00485 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

LIHC, KICH, and STAD are the cancer types where LINC00485 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00485 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Male	All	+0.055	<.001	7	view →
KICH	All	All	−0.016	.002	4	view →
STAD	Female	All	+0.048	.013	3	view →
LUSC	All	All	+0.012	.008	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

LINC00485–LIHC

Open the LIHC breakdown →